Latest oppositions filed by Ares Trading Sa

This table presents recent patent oppositions filed by Ares Trading Sa against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3144318Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRING B.V.Mar 25, 2021
EP2542590Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion ProteinsTHE JOHNS HOPKINS UNIVERSITYFeb 2, 2018

The following table provides an overview of the latest patents of Ares Trading Sa that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3061013Apr 22, 2020Patient Care System Reporting Adherence To Treatment Regimen1
EP2854790Aug 29, 2018Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media1
EP3145487Aug 22, 2018Liquid Pharmaceutical Composition1
EP3148510Jun 27, 2018Liquid Pharmaceutical Composition2